Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo()

BACKGROUND: Ozenoxacin is a topical antibiotic approved in the United States for treatment of impetigo in adults and children age ≥2 months. This analysis evaluated the efficacy and safety of ozenoxacin in specific pediatric age groups. METHODS: Data for children aged 2 months to <18 years recrui...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebert, Adelaide A., Rosen, Theodore, Albareda López, Núria, Zsolt, Ilonka, Masramon, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105648/
https://www.ncbi.nlm.nih.gov/pubmed/32258344
http://dx.doi.org/10.1016/j.ijwd.2019.10.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105648/
https://www.ncbi.nlm.nih.gov/pubmed/32258344
http://dx.doi.org/10.1016/j.ijwd.2019.10.008

Ejemplares similares